Correlation Between Suzhou Novoprotein and Shanghai Sanyou

Can any of the company-specific risk be diversified away by investing in both Suzhou Novoprotein and Shanghai Sanyou at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Suzhou Novoprotein and Shanghai Sanyou into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Suzhou Novoprotein Scientific and Shanghai Sanyou Medical, you can compare the effects of market volatilities on Suzhou Novoprotein and Shanghai Sanyou and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Suzhou Novoprotein with a short position of Shanghai Sanyou. Check out your portfolio center. Please also check ongoing floating volatility patterns of Suzhou Novoprotein and Shanghai Sanyou.

Diversification Opportunities for Suzhou Novoprotein and Shanghai Sanyou

0.91

Correlation Coefficient

Suzhou Novoprotein  Shanghai Sanyou

Almost no diversification

The 3 months correlation between Suzhou and Shanghai is 0.91. Overlapping area represents the amount of risk that can be diversified away by holding Suzhou Novoprotein Scientific and Shanghai Sanyou Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Shanghai Sanyou Medical and Suzhou Novoprotein is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Suzhou Novoprotein Scientific are associated (or correlated) with Shanghai Sanyou. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Shanghai Sanyou Medical has no effect on the direction of Suzhou Novoprotein i.e., Suzhou Novoprotein and Shanghai Sanyou go up and down completely randomly.

Pair Corralation between Suzhou Novoprotein and Shanghai Sanyou

Assuming the 90 days trading horizon Suzhou Novoprotein Scientific is expected to under-perform the Shanghai Sanyou. But the stock apears to be less risky and, when comparing its historical volatility, Suzhou Novoprotein Scientific is 1.06 times less risky than Shanghai Sanyou. The stock trades about -0.04 of its potential returns per unit of risk. The Shanghai Sanyou Medical is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  1,886  in Shanghai Sanyou Medical on September 4, 2024 and sell it today you would earn a total of  296.00  from holding Shanghai Sanyou Medical or generate 15.69% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Strong
Accuracy	100.0%
Values	Daily Returns

Suzhou Novoprotein Scientific  vs.  Shanghai Sanyou Medical

Suzhou Novoprotein

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Suzhou Novoprotein Scientific are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Suzhou Novoprotein sustained solid returns over the last few months and may actually be approaching a breakup point.

Shanghai Sanyou Medical

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Shanghai Sanyou Medical are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Shanghai Sanyou sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Suzhou Novoprotein and Shanghai Sanyou

The main advantage of trading using opposite Suzhou Novoprotein and Shanghai Sanyou positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Suzhou Novoprotein position performs unexpectedly, Shanghai Sanyou can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shanghai Sanyou will offset losses from the drop in Shanghai Sanyou's long position.

The idea behind Suzhou Novoprotein Scientific and Shanghai Sanyou Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.